snyderman nancy lynn MD

DirectorAlkermes plc. (ALKS) · full profile →Form 4 · filed Aug 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.2M
Net Open-Market Flow
-$2.2M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 3, 2026Option exercise(M)28K$46.72$1.3M43K
Aug 3, 2026Option exercise(M)17K$46.72$772K60K
Aug 3, 2026Sell(S)44K$50.35$2.2M15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 3, 2026Option exercise(M)28K$00
Aug 3, 2026Option exercise(M)17K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001520262-26-000111) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ALKS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001520262-26-000111"
Ask your agent
Use Arkolith to summarize insider buying and selling at Alkermes plc.
over the last 90 days and cite the filings.